Tag Archives: tenofovir

Pro-Choice Friday News Rundown

Posted on by

  • Deja Foxx

    Let’s kick this thing off with some good news — two states have passed laws making it easier for women to access birth control! Yay! (Elite Daily)

  • If you live in the Phoenix metro area, you may wanna check out this handy map on the prevalence of STDs in your ZIP code! (ABC 15)
  • In other local news, Tucson teen Deja Foxx is a fearless powerhouse. She courageously advocates for others, heroically stood up to Sen. Jeff Flake, and sings the praises of Planned Parenthood every chance she gets. We are SO in awe of her and SO thankful for her advocacy! (WaPo)
  • Extensive research by the National Bureau of Economic Research shows there are broad economic benefits of increased contraception use — not just for women but for society overall. (Salon)
  • Of course sexism played a huge role in Hillary’s 2016 election loss. (XX Factor)
  • Rewire‘s Yamani Hernandez explains why framing abortion as an economic issue that affects our survival may be the only way to make people understand how crucial our right to this choice is. (Rewire)
  • Texas’ maternal mortality rate doubled over a two-year period. Not coincidentally, this was the same two-year period of time in which the state gutted Planned Parenthood and forced most of our health centers in the state to close. Additionally, more than half of all births in Texas are paid for by Medicaid, but coverage for new mothers ends just 60 days after childbirth. The majority of the 189 maternal deaths the task force looked at from 2011 to 2012 occurred after the 60-day mark. (Texas Observer)
  • Texas also has the highest birth rate in the U.S. (more than half paid for through Medicaid), and one of the highest teen pregnancy rates in the country. Medicaid births — most likely unintended pregnancies — rose in areas where access to PP was barred. (Austin Chronicle)
  • And in case you were wondering, Texas is not done clobbering reproductive options and rights. Their governor just signed what is being described as a “sweeping anti-abortion law.” (The Cut)
  • The latest medical science discovery: A vaginal gel containing tenofovir, an antiretroviral drug used to treat HIV infection, was three times as effective at preventing HIV in women who had healthy vaginal bacterial communities as it was in women with a less beneficial mix. (Science News)
  • Gotta love this headline: “President Who Bragged About Extramarital Sex Appoints Top Abstinence Advocate to HHS” (XX Factor)

STD Awareness: Are Condoms Really Necessary?

Posted on by

condoms in packetsCondoms are one of the best ways for sexually active people to avoid sexually transmitted diseases (STDs), but many worry that people are becoming more lax about protecting themselves. There are all kinds of myths swirling around about condoms — such as that they aren’t effective or that they kill the mood. And, thanks to anti-HIV medications, some people no longer see condom use as a matter of life or death.

The Centers for Disease Control and Prevention (CDC) recently announced that 2014 saw record highs in chlamydia, syphilis, and gonorrhea, which is a stark reminder that condoms protect against more than just HIV. So, even if you’re using medications to protect yourself from HIV, remember that syphilis is making a comeback, and can cause serious damage or even death when untreated, and that gonorrhea is rapidly evolving resistance to the last good drugs we have to treat it. Condoms are just as relevant as ever!

HIV

In 2014, the CDC announced it would start using the term “condomless sex” instead of “unprotected sex” to recognize that people could engage in condom-free sex, but still protect themselves from HIV by using Truvada, or pre-exposure prophylaxis (PrEP). Truvada is the first drug approved by the FDA to prevent HIV, and it can be taken by HIV-negative individuals to help their body ward off the virus before an infection can establish itself. The pill must be taken daily — using it inconsistently reduces its effectiveness. Continue reading →

Let’s Talk Contraception: The One-Size Diaphragm, a New Contraceptive

Posted on by

SILCS diaphragmIn June of 2013, a new barrier contraceptive, the SILCS diaphragm, entered the market in Europe, and in May of this year, it became available in Canada. The new diaphragm is called the Caya contoured diaphragm, and it’s being marketed as “not your mother’s diaphragm.” This is exciting because Caya is a user-friendly, one-size diaphragm that can fit most users without the need of a pelvic exam. It is being sold through pharmacies and health care providers.

An over-the-counter, one-size-fits-most diaphragm could be available in U.S. pharmacies as early as next year.

The SILCS diaphragm was developed with the financial help of the U.S. Agency for International Development (USAID), by CONRAD and PATH, nonprofit leaders in global contraceptive research. USAID was created in 1961 by President Kennedy, and provides financial support to improving the lives of people in developing countries, including support to find safe, effective, and acceptable contraceptives in low-resource areas. CONRAD began in 1986 as a division of the obstetrics and gynecology department of East Virginia Medical School in Norfolk, Virginia, and collaborates on research to improve reproductive health around the world. PATH is a Seattle-based international nonprofit that works globally to develop and deliver health solutions that are affordable and effective, including vaccines, drugs, and medical devices.

Caya works as well as traditional diaphragms, but has been redesigned to make it easier to insert and remove. During its development, many women, their partners, and health-care providers on four continents had input on its design. Continue reading →

Let’s Talk Contraception: New Contraceptives and HIV Protection

Posted on by
This ring, currently under development, can be inserted into the vagina to prevent both pregnancy and HIV transmission. Image: USAID

This ring, currently under development, might reduce risk for both pregnancy and HIV transmission. Image: USAID

The World Health Organization estimated that in 2012 there were 35.3 million people worldwide living with HIV. A whopping 69 percent of them live in sub-Saharan Africa. Save the Children reports that 2 out of 5 children born in developing countries are the result of unintended pregnancies.

Condoms remain the gold standard for protection against HIV transmission. But not all women are able to negotiate condom use. The same can be said for contraceptives. Health-care providers in some areas of the world are not even able to provide condoms consistently due to political or financial pressures.

An intravaginal ring under development might protect against pregnancy, HIV, and genital herpes.

But there are nonprofit groups researching and developing products to meet the needs of women in these countries. With the financial backing of the U.S. Agency for International Development (USAID), CONRAD, a nonprofit committed to improving reproductive health globally, is testing a new intravaginal ring that combines a hormonal contraceptive, levonorgestrel, and an HIV microbicide, tenofovir, in the same product. When inserted vaginally, it slowly dispenses both drugs to prevent pregnancy and HIV transmission. Continue reading →